Beneficial effect of yam on the amyloid β-protein, monoamine oxidase B and cognitive deficit in mice with accelerated senescence

Journal of the Science of Food and Agriculture

Volumn 86, Issue 10, 2006, Pages 1517-1525

  Chan, Yin Ching ^a   Hsu, Cheng Kuang ^b   Wang, Ming Fu ^a   Liao, Jiunn Wang ^c   Su, Ting Ya ^a  

^a PROVIDENCE UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Amyloid protein; Antioxidant; Cognitive ability; Mice; Monoamine oxidase activity; Yam

Indexed keywords

DIOSCOREA ALATA;

EID: 33746107623     PISSN: 00225142     EISSN: 10970010     Source Type: Journal    
DOI: 10.1002/jsfa.2536     Document Type: Article

References (71)

1. Friedlich AL and Butcher LL, Involvement of free oxygen radicals in β-amyloidosis: an hypothesis. Neurobiol Aging 15:443-455 (1994).
2. Montine TJ, Markesbery WR, Zackert W, Sanchez SC, Roberts LJ and Morrow JD, The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with ApoE genotype in Alzheimer's disease patients. Am J Pathol 155:863-868 (1999).
3. Smith MA, Richey Harris PL, Sayre LM, Beckman JS and Perry G, Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci 17:2653-2657 (1997).
4. Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, Smith MA, et al, Evidence of oxidative stress and in vivo neurotoxicity of β-amyloid in a transgenic mouse model of Alzheimer's disease. Am J Pathol 152:871-877 (1998).
5. Perry G and Smith MA, A central role for oxidative damage in the pathogenesis and therapeutics of Alzheimer's disease. Alzheimer's Res 2:319-324 (1997).
6. Smith MA, Hirai K, Hsiao K, Pappolla MA, Harris PLR and Siedlank SL, et al, Amyloid-β depositions in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem 70:2212-2215 (1998).
7. Behl C, Davis JB, Lesley R and Schubert D, Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827 (1994).
8. Behl C, Davis J, Cole GM and Schubert D, Vitamin E protects nerve cells from amyloid β -protein toxicity. Biochem Biophys Res Commun 186:944-950 (1992).
9. Goodman G, Steiner MR, Steiner SM and Mattson MP, Nordihydroguaiaretic acid protects hippocampal neurons against amyloid β -peptide toxicity and attenuates free radical and calcium accumulation. Brain Res 654:171-176 (1994).
10. Bickford PC, Gould T, Briederick L, Chadman K, Pollock A, Young D, et al., Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res 866:211-217 (2000).
11. Josson SS, Gillberg PG, Gottfries CG, Karlsson I and Oreland L, Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study. Neuroscience 145:1-12 (1991).
12. Saura J, Luque AM, Cesura M, Da Prada M, Chan-Palay V, Huber G, et al, Increased monoamine oxidase B activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 62:15-30 (1994).
13. Sherif F, Gottfries CG, Alafuzoff I and Oreland L, Brain γ-aminobutyrate aminotransferase (GABA-T) and monoamine oxidase (MAO) in patients with Alzheimer's disease. J Neural Transm Park Dis Dement Sect 4:227-240 (1992).
14. Alper G, Girgin FK, Ozgonul M, Mentes G and Ersoz B, MAO inhibitors and oxidant stress in aging brain tissue. Eur Neuropsychopharmacol 9:247-252 (1999).
15. Kaur C and Kapoor HC, Anti-oxidant activity and total phenolic content of some Asian vegetables. Int J Food Sci Technol 37:153-161 (2002).
16. Salah N, Miller NJ, Paganga G, Tijburg L, Bolwell GP and Rice-Evans C, Polyphenolic flavonols as scavenger of aqueous phase radicals and as chain breaking antioxidant. Arch Biochem Biophys 322:339-346 (1995).
17. Chan YC, Hsu CK, Wang MF and Su TY, Reduction of the cognitive deterioration and hippocampus morphology changes in senescence accelerated mice by diet containing yam. Int J Food Sci Technol 39:99-107 (2004).
18. Wanasundera JPD and Ravindran G, Nutrition assessment of yam (Dioscorea alata) tubers. Plant Foods Hum Nutr 46:33-39 (1994).
19. Baquar SR and Oke OL, Protein in Nigerian yams (Dioscorea spp.). Nutr Rep Int 14:237-248 (1976).
20. Bradbury JH, The chemical composition of tropical root crops. ASEAN [Association of South East Asian Nations] Food J 4:3-13 (1988).
21. FAO, Food Composition Table for Use in East Asia. Food and Agriculture Organization, Rome (1972).
22. Marcus DL, Thomas C, Rodriguez C, Simberkoff K, Tasi JS, Strfaci JA, et al, Increased peroxideratoin and reduced antioxidant enzyme activity in Alzheimer's disease. Exp Neurol 150:40-44 (1998).
23. Martin FW and Thompson AE, Protein content and amino acid balance of yams. J Agric Univ Puerto Rico 57:78-83 (1973).
24. Splittstoesser WE, Martin FW and Rhodes AM, The amino acid composition of five species of yams (Dioscorea). J Am Hort Sci 98:563-567 (1973).
25. Farombi EO, Britton G and Emerole GO, Evaluation of the antioxidant activity and partial characterization of extracts from browned yam flour diet. Food Res Int 33:493-499 (2000).
26. Chen HL, Chang CT and Wang CH, The Trophic Effects of Taiwanese Yam (Dioscorea spp.) Tubers on the Epithelial Cells in the Lower Gut of Mice. Health Food Society of Taiwan, Taipei, Taiwan (2002).
27. Fang MC and Kong RL, Immuno-bioactivity of Yam Crude Polysaccharide and Yam Yogurt in Cell Culture and Mice. Health Food Society of Taiwan, Taipei, Taiwan (2002).
28. Araghiniknam M, Chung S, Nelson-White T, Eskelson C and Watson RR, Antioxidant activity of dioscorea and dehydroepiandrosterone (DHEA) in older humans. Life Sci 59:147-157 (1996).
29. Hikino H, Konno C, Takahashi M, Murakami M, Kato Y, Karikura M, et al, Isolation and hypoglycemic activity of dioscorans A, B, C, D, E and F, glycans of Dioscorea japonica Rhizophors. Planta Med 52:168-171 (1986).
30. Takeda T, Hosokawa M and Higuchi K, Senescence-accelerated mouse (SAM): a novel murine model of aging, in The SAM Model of Senescence, ed. by Taketa T. Elsevier Science, Amsterdam, pp. 15-22 (1994).
31. Popesko P, Rajtová V and Horák J, Mouse. A Color Atlas of the Anatomy of Small Laboratory Animals, Vol. 2. Wolfe Publishing, London, pp. 105-166 (1992).
32. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, et al, Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease. J Neurosci 20:5709-5714 (2000).
33. Akiyama H, Kameyyama M, Akiguchi I, Sugiyama H, Kawamata T, Fukuyama H, et al, Periodic acid-Schiff (PAS)-positive, granular structures increase in the brain of senescence accelerated mouse (SAM). Acta Neuropathol (Berl) 72:124-129 (1986).
34. Liu JS, Huo IC, Chang WF, Chu CP and Wang SJ, Periodic acid Schiff (PAS) method, in An Atlas and Manual of Histopathological Staining Methods - Histochemistry, ed. by Research Institute of Taiwan. Ten-Huo Press, Maiole, Taiwan, pp. 100-106 (1996).
35. Chen TH, Wang MF, Liang YF, Komatsu T, Chan YC, Chung SY, et al, Dietary nucleoside-nucleotide mixture may reduce memory deterioration in old senescence accelerated mice (SAM). J Nutr 130:3085-3089 (2000).
36. Kraml M, A rapid fluorometric determination of MAO. Biochem Pharmacol 14:1684-1686 (1965).
37. Ohkawa H, Ohishi N and Yagi K, Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358 (1979).
38. Ellman GL and Lysko H, A precise method for determination of whole blood and plasma sulfhydryl group. Anal Biochem 93:98-105 (1978).
39. Marklund S and Marklund G, Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 47:469-474 (1974).
40. Higuchi K, Xing Y, Fu X, Korenaga T, Guo Z, Nakanura A, et al, Mouse senile amyloidosis in the SAM model, in The Senescence-Accelerated Mouse (SAM): an Animal Model of Senescence, ed. by Nomura Y, Takeda T and Okuma Y. International Congress Series 1260. Elsevier, Amsterdam, pp. 35-40 (2004).
41. Flood JF and Morley JE, Age-related changes in footshock avoidance acquisition and retention in senescence-accelerated mouse (SAM). Neurol Aging 14:153-157 (1993).
42. Ohta A, Hirano T, Yagi H, Tanaka S, Hosokawa M and Takeda T, Behavioral characteristics of the SAM-P/8 strain in Sidman active avoidance task. Brain Res 498:195-198 (1989).
43. Kim HC, Bing G, Jhoo WK, Kim WK, Shin EJ, Park ES, et al, Oxidative damage causes formation of lipofuscin-like substances in the hippocampus of the senescence-accelerated mouse after kainate treatment. Behav Brain Res 131:211-220 (2002).
44. Liu J and Mori A, Age-associated changes in superoxide dismutase activity, thiobarbituric acid reactivity and reduced glutathione level in the brain and liver in senescence accelerated mice (SAM): a comparison with ddY mice. Mech Ageing Dev 71:23-30 (1993).
45. Borek C, Antioxidant health effects of aged garlic extract. J Nutr 131:1010S-1015S (2001).
46. Diamond BJ, Shiflett SC, Feiwel N, Matheis RJ, Noskin O, Richards JA, et al., Ginkgo biloba extract: mechanisms and clinical indications. Arch Phys Med Rehabil 81:668-678 (2000).
47. He S, Zhan T and Wang S, Study on chemistry and antioxidation activity of water soluble polysaccharides of Zhizoma Dioscoreae Oppositae. J Chin Pharm Univ 25:373-375 (1994).
48. Hou WC, Lee MH, Chen HJ, Liang WL, Han CH, Liu ZW, et al, Antioxidant activities of dioscorin, the storage protein of yam (Dioscorea batatas) tuber. J Agric Food Chem 49:4956-4960 (2001).
49. Nabeshima T and Nitta A, Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. Tohoku J Exp Med 174:241-249 (1994).
50. Nitta A, Fukata T, Hasegawa T and Nabeshima T, Continuous infusion of beta-amyloid protein into cerebral ventricle induces learning impairment and neuronal and morphological degeneration. Jpn J Pharmacol 73:51-57 (1997).
51. Yamada K and Nabeshima T, Animal models of Alzheimer's disease and evaluation of anti-dementia drugs. Pharmacol Ther 88:93-113 (2000).
52. Yamada K, Tanaka T, Han D, Senzaki K, Kameyama T and Nabeshima T, Protective effects of idebenone and alpha-tocopherol on beta-amyloid1-42 induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo. Eur J Neurosci 11:83-90 (1999).
53. Morley JE, Kumar VB, Bernardo AE, Farr SA, Uezu K, Tumosa N, et al, Beta-amyloid precursor polypeptide in SAMPS mice affects learning and memory. Peptides 21:1761-1767 (2000).
54. Amano T, Nakanishi H, Oka M and Yamamoto K, Increased expression of cathepsins E and D in reactive microglial cells associated with spongiform degeneration in the brain stem of senescence-accelerated mouse. Exp Neurol 136:171-182 (1995).
55. Weyler W, Hsu YP and Breakefield XO, Biochemistry and genetics of monoamine oxidase. Pharmacol Ther 47:391-417 (1990).
56. Fahn S and Cohen G, The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann Neurol 32:804-812 (1992).
57. Kornhuber J, Konradi C, Mack-Burkhardt F, Riederer P, Heinsen H and Beckmann H, Ontogenesis of monoamine oxidase-A and -B in the human brain frontal cortex. Brain Res 499:81-86 (1989).
58. Sparks DL, Woeltz VM and Markesbery WR, Alterations in brain monoamine oxidase activity in aging, Alzheimer's disease and Pick's disease. Arch Neurol 48:718-721 (1991).
59. Volchegorskii IA, Shemyakov SE, Turygin VV and Malinovskaya NV, Comparative analysis of age-related changes in activities of monoamine oxidase-B and antioxidant defense enzymes in various structures of human brain. Bull Exp Biol Med 132:760-762 (2001).
60. Shih JC, Monoamine oxidase in aging human brain, in Monoamine Oxidase: Structure, Function and Altered Functions, ed. by Singer TP, Von Korff RW and Murphy DL. Academic Press, New York, pp. 413-421 (1979).
61. Leung TKC, Lim L and Lai JCK, Brain regional distributions of monoamine oxidase activities in postnatal development in normal and chronically manganese-treated rats. Metab Brain Dis 8:137-149 (1993).
62. Benedetti SM and Keane PE, Differential changes in monoamine oxidase A and B activity in the aging rat brain. Neurochemistry 35:1026-1032 (1980).
63. Irwin I, Finnegan KT, Delanney LE, Di Monte D and Langston JW, The relationships between aging, monoamine oxidase, striatal dopamine and the effects of MPTP in C57BL/6 mice: a critical reassessment. Brain Res 572:224-231 (1992).
64. Komesaroff PA, Black CV, Cable V and Sudhir K, Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 4:144-150 (2001).
65. Cayen MN and Dvornik D, Effect of diosgenin on lipid metabolism in rats. J Lipid Res 20:162-174 (1979).
66. Reeves PG, Components of the AIN-93 diets as improvements in the AIN-76A diet. J Nutr 127:838S-841S (1997).
67. Lesser G, Kandiah K, Libow LS, Likourezos A, Breuer B, Marin D, et al, Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease. Dement Geriatr Cogn Disord 12:138-145 (2001).
68. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, et al, Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 56:1683-1689 (2001).
69. Borroni B, Chlciaghi F, Lenzi GL, Caimi L, Cattabeni F, Luca MD, et al., High cholesterol affects platelet APP processing in controls and in AD patients. Neurobiol Aging 24:631-636 (2003).
70. Wood WG, Eckert GP, Igbavboa U and Müller WE, Amyloid beta-protein interactions with membranes and cholesterol: causes or casualities of Alzheimer's disease. Biochim Biophys Acta 1610:281-290 (2003).
71. Kotter HU, Hampel H and Moller HJ, Total serum cholesterol and triglycerides in patients with Alzheimer's disease and healthy controls. Neurobiol Aging 17:S95-S96 (1996).